Document Detail

A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients.
MedLine Citation:
PMID:  23037867     Owner:  NLM     Status:  Publisher    
In the attempt to establish key therapy definitions and provide shared approaches to invasive fungal diseases in neutropenic patients, trials of empiric, preeemptive and targeted antifungal therapy (EAT, PAT and TAT) were reviewed, and a Consensus Development Conference Project was convened. The Expert-Panel concurred that all antifungal treatments, including EAT, should always follow an adequate diagnostic strategy and that the standard definition of PAT may be misleading: being PAT guided by the results of a diagnostic work-up, it should better be termed diagnostic-driven antifungal therapy (DDAT). The Expert-Panel agreed that radiological findings alone are insufficient for the choice of a TAT and that the identification of the etiologic pathogen is needed. The Consensus Agreement proceeded identifying which clinical and microbiological findings were sufficient to start a DDAT and which were not. Finally, an algorithm to rationalize the choice of antifungal drugs on the basis of clinical manifestations, antifungal prophylaxis, instrumental and laboratory findings was drawn up. Copyright © 2012 John Wiley & Sons, Ltd.
Corrado Girmenia; Franco Aversa; Alessandro Busca; Anna Candoni; Simone Cesaro; Mario Luppi; Livio Pagano; Giuseppe Rossi; Adriano Venditti; Anna Maria Nosari
Related Documents :
24662877 - There's no place like home: boarding surgical icu patients in other icus and the effect...
24867967 - Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from com...
23055907 - Retrospective analysis of the initiation of antibiotic therapy in severe sepsis in pedi...
23982057 - Severe measles infection: the spectrum of disease in 36 critically ill adult patients.
20019607 - Considering energy deficit in the intensive care unit.
22553547 - Traumatic optic neuropathy: a review of 24 patients.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-5
Journal Detail:
Title:  Hematological oncology     Volume:  -     ISSN:  1099-1069     ISO Abbreviation:  Hematol Oncol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8307268     Medline TA:  Hematol Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 John Wiley & Sons, Ltd.
Dipartimento di Ematologia, Oncologia, Anatomia Patologica e Medicina Rigenerativa, Azienda Policlinico Umberto I, Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Stressful life events and cognitive decline in late life: moderation by education and age. The Cache...
Next Document:  Self-assembled nanostructures of optically active phthalocyanine derivatives. Effect of central meta...